BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11310595)

  • 1. Imidazoline-modified benzylimidazolines as h5-HT(1D/1B) serotonergic ligands.
    Prisinzano T; Law H; Dukat M; Slassi A; MaClean N; Demchyshyn L; Glennon RA
    Bioorg Med Chem; 2001 Mar; 9(3):613-9. PubMed ID: 11310595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzylimidazolines as h5-HT1B/1D serotonin receptor ligands: a structure-affinity investigation.
    Law H; Dukat M; Teitler M; Lee DK; Mazzocco L; Kamboj R; Rampersad V; Prisinzano T; Glennon RA
    J Med Chem; 1998 Jun; 41(13):2243-51. PubMed ID: 9632357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and serotonergic activity of 3-[2-(pyrrolidin-1-yl)ethyl]indoles: potent agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B receptor.
    Sternfeld F; Guiblin AR; Jelley RA; Matassa VG; Reeve AJ; Hunt PA; Beer MS; Heald A; Stanton JA; Sohal B; Watt AP; Street LJ
    J Med Chem; 1999 Feb; 42(4):677-90. PubMed ID: 10052975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of human serotonin 1D and 1B receptors using [3H]-GR-125743, a novel radiolabelled serotonin 5HT1D/1B receptor antagonist.
    Doménech T; Beleta J; Palacios JM
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):328-34. PubMed ID: 9303569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How efficacious are 5-HT1B/D receptor ligands: an answer from GTP gamma S binding studies with stably transfected C6-glial cell lines.
    Pauwels PJ; Tardif S; Palmier C; Wurch T; Colpaert FC
    Neuropharmacology; 1997; 36(4-5):499-512. PubMed ID: 9225275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-(Piperazinylpropyl)indoles: selective, orally bioavailable h5-HT1D receptor agonists as potential antimigraine agents.
    Chambers MS; Street LJ; Goodacre S; Hobbs SC; Hunt P; Jelley RA; Matassa VG; Reeve AJ; Sternfeld F; Beer MS; Stanton JA; Rathbone D; Watt AP; MacLeod AM
    J Med Chem; 1999 Feb; 42(4):691-705. PubMed ID: 10052976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.
    Leysen JE; Gommeren W; Heylen L; Luyten WH; Van de Weyer I; Vanhoenacker P; Haegeman G; Schotte A; Van Gompel P; Wouters R; Lesage AS
    Mol Pharmacol; 1996 Dec; 50(6):1567-80. PubMed ID: 8967979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inverse agonist properties of antipsychotic agents at cloned, human (h) serotonin (5-HT)(1B) and h5-HT(1D) receptors.
    Audinot V; Newman-Tancredi A; Cussac D; Millan MJ
    Neuropsychopharmacology; 2001 Sep; 25(3):410-22. PubMed ID: 11522469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SB-216641 and BRL-15572--compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors.
    Price GW; Burton MJ; Collin LJ; Duckworth M; Gaster L; Göthert M; Jones BJ; Roberts C; Watson JM; Middlemiss DN
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):312-20. PubMed ID: 9303567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonistic properties of alniditan, sumatriptan and dihydroergotamine on human 5-HT1B and 5-HT1D receptors expressed in various mammalian cell lines.
    Lesage AS; Wouters R; Van Gompel P; Heylen L; Vanhoenacker P; Haegeman G; Luyten WH; Leysen JE
    Br J Pharmacol; 1998 Apr; 123(8):1655-65. PubMed ID: 9605573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric receptor analysis of the ketanserin binding site in the human 5-Hydroxytryptamine1D receptor: importance of the second extracellular loop and fifth transmembrane domain in antagonist binding.
    Wurch T; Colpaert FC; Pauwels PJ
    Mol Pharmacol; 1998 Dec; 54(6):1088-96. PubMed ID: 9855638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in 5-HT1B/1D receptor antagonists and agonists and their potential therapeutic applications.
    Slassi A
    Curr Top Med Chem; 2002 Jun; 2(6):559-74. PubMed ID: 12052194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-Hydroxy-1-[3-(5-(1,2,4-triazol-4-yl)-1H-indol-3-yl)propyl]piperidines: selective h5-HT1D agonists for the treatment of migraine.
    Bourrain S; Neduvelil JG; Beer MS; Stanton JA; Showell GA; MacLeod AM
    Bioorg Med Chem Lett; 1999 Dec; 9(23):3369-74. PubMed ID: 10612601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors.
    Schlicker E; Fink K; Molderings GJ; Price GW; Duckworth M; Gaster L; Middlemiss DN; Zentner J; Likungu J; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):321-7. PubMed ID: 9303568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of 5-HT(1B/1D) and 5-HT2A receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries.
    Ellwood AJ; Curtis MJ
    Br J Pharmacol; 1997 Nov; 122(5):875-84. PubMed ID: 9384503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dimers of 5HT1 ligands preferentially bind to 5HT1B/1D receptor subtypes.
    Perez M; Jorand-Lebrun C; Pauwels PJ; Pallard I; Halazy S
    Bioorg Med Chem Lett; 1998 Jun; 8(11):1407-12. PubMed ID: 9871775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-(Sulfonyl)oxy-tryptamines and ethylamino side chain restricted derivatives. Structure-affinity relationships for h5-HT1B and h5-HT1D receptors.
    Barf T; Wikström H; Pauwels PJ; Palmier C; Tardif S; Lundmark M; Sundell S
    Bioorg Med Chem; 1998 Sep; 6(9):1469-79. PubMed ID: 9801818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cloning and pharmacological characterization of guinea pig 5-HT1B and 5-HT1D receptors.
    Zgombick JM; Bard JA; Kucharewicz SA; Urquhart DA; Weinshank RL; Branchek TA
    Neuropharmacology; 1997; 36(4-5):513-24. PubMed ID: 9225276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of 5-HT(1B), 5-HT(1D) and 5-HT(1F) receptor expression in rat trigeminal and dorsal root ganglia neurons: relevance to the selective anti-migraine effect of triptans.
    Classey JD; Bartsch T; Goadsby PJ
    Brain Res; 2010 Nov; 1361():76-85. PubMed ID: 20833155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Actions of roxindole at recombinant human dopamine D2, D3 and D4 and serotonin 5-HT1A, 5-HT1B and 5-HT1D receptors.
    Newman-Tancredi A; Cussac D; Audinot V; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):447-53. PubMed ID: 10431754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.